Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Background: ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and...
WHAT'S UP IN
Background: ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and...
